PKCβ critically regulates D2autoR‐activated dopamine transporter (DAT) transport and dopaminergic signaling, emerging as a potential drug target for correcting abnormal extracellular dopamine levels in diseases such as drug addiction and schizophrenia [84]. The gene discussed is SLC6A3; the disease is schizophrenia.